Sonia Gandhi has written a letter to Prime Minister Narendra Modi over new vaccine policy. She has described the government's policy as arbitrary and discriminatory.
Leading vaccine maker Bharat Biotech and the Indian Council of Medical Research (ICMR) announced interim results from phase 3 clinical trials of coronavirus Covaxin, which show 78 per cent overall clinical efficacy and 100 per cent efficacy against severe Covid-19.
Bihar government will run a free vaccination drive against coronavirus for people above 18 years of age, Bihar Chief Minister Nitish Kumar informed on Wednesday.
More than 21,000 people tested positive for COVID-19 after taking the first dose of either Covishield or Covaxin, while over 5,500 contracted the infection after taking the second dose, the Centre said on Wednesday.
India's indigenously developed Bharat Biotech's coronavirus vaccine — Covaxin — works against multiple variant of Covid19. According to the Indian Council of Medical Research (ICMR) study, COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well.
ICMR study shows Covaxin neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well.
The Biden administration has conveyed to India that they understand India's pharmaceutical requirements and has promised to review embargo on Covid-19 vaccine raw material.
COVID-19 vaccine: SII will supply 200 million doses and Bharat Biotech is to supply another 90 million doses to the government by July at a pre-agreed rate of Rs 150 per dose.
Union Health Minister Harsh Vardhan on Sunday said there will be a 10 times rise in Covaxin vaccine production by September while manufacture of remdesivir jabs, an anti-viral drug against COVID-19, will be doubled to 74.1 lakh each month by May.
The Centre has granted permission to Haffkine Institute, Mumbai to manufacture Bharat Biotech's Covid-19 vaccine Covaxin
Currently, two Covid-19 vaccines -- Covaxin and Covishield are being used for inoculation in the country. India has just granted permission for emergency use of Russia's Sputnik V vaccine.
The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin.
Two Covid-19 vaccines -- Covaxin and Covishield are being used for inoculation in India. India has just granted permission for emergency use of Russia's Sputnik V vaccine.
The Drug Controller General of India (DCGI) has registered the vaccine under the emergency use authorisation procedure.
Delhi Deputy Chief Minister Manish Sisodia along with his wife Seema Sisodia took first shot of the COVID-19 vaccine at Maulana Azad Medical College.
The expert panel of India's drug regulator, DCGI, has permitted Bharat Biotech to give the third dose of Covaxin to a few volunteers in its clinical trials of the COVID-19 vaccine.
The third phase of Covid-19 vaccination drive will include those who are above 45 years. People can book an appointment for COVID-19 vaccination via CoWIN. Beneficiaries can also go for on-site registration.
India started supplying the vaccine doses to foreign countries on January 20. The first countries to receive such vaccines were from the neighbourhood.
Bharat Biotech had applied for emergency use authorisation for its vaccine candidate, Covaxin, in Nepal on January 13. Covaxin demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials India.
Ambassador of Paraguay to India, Fleming Raul Duarte requested for supply of COVAXIN, the COVID-19 vaccine by Hyderabad-based 'Bharat Biotech' and also heaped praises on India for its vaccine diplomacy.
Top News
Latest News
